Janice fitzgibbon’s testimony at fda public hearing on benlysta

Janice fitzgibbon\’s testimony at fda public hearing on benlysta

On November 16, 2010 the FDA held hearings to discuss BENLYSTA, sponsored by Human Genome Sciences, for the proposed indication of reducing disease activity in adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE). Click bit.ly to access transcript of testimony from Janice Fitzgibbon, Member of the Lupus Foundation of America, DC-MD-VA Chapter….



Janice fitzgibbon\’s testimony at fda public hearing on benlysta